Glucagon does not Affect Catecholamine Release in Primary Cultures of Bovine Adrenal Chromaffin Cells

Abstract

Objective: Human pheochromocytoma tumor cells express glucagon receptors, and bolus i. v. glucagon injection rapidly increases plasma epinephrine levels, suggesting that glucagon can directly stimulate adrenomedullary secretion. In this study, we tested whether the catecholamine secretory response to glucagon was present in bovine chromaffin cells or exclusive to the tumor cells. Design and Methods: Adrenomedullary cells were cultured in 24-well plates (10⁶ cells per well). After 48 - 72 hours, wells were incubated for 1 - 20 minutes with (1) incubation medium (control), (2) catecholamine secretagogues (nicotine or potassium ion), or (3) glucagon (10 ^{- 8} to 10 ^{- 5} M). After incubation, catecholamine contents in medium and cells were assayed by high-pressure liquid chromatography with electrochemical detection. Fractional release rates of epinephrine, norepinephrine, and dopamine were calculated and compared to controls. Reverse-transcriptase PCR was performed to compare expression of mRNA of the glucagon receptor in chromaffin cells and pheochromocytoma cells. Results: Nicotine and potassium evoked time-dependent release of epinephrine, norepinephrine, and dopamine. Glucagon did not affect catecholamine secretion at any concentration. Reverse-transcriptase PCR failed to detect mRNA for glucagon receptor in bovine adrenomedullary cells, but did detect it in human pheochromocytoma cells. Conclusions: In contrast to pheochromocytoma tumor cells, bovine adrenomedullary chromaffin cells do not express the glucagon receptor, and therefore do not secrete catecholamines in response to glucagon.

Key words

Adrenal medulla - Glucagon - Catecholamines - Chromaffin cell - Pheochromocytoma

References

• 1 Bravo E L, Tarazi R C, Gifford R W, Stewart B H. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.  N Engl J Med. 1979;  301 682-686
• 2 Bravo E L. Pheochromocytoma. Current concepts in diagnosis, localization, and management.  Prim Care. 1983;  10 75-86
• 3 Lawrence A. Glucagon provocative test for pheochromocytoma.  Ann Intern Med. 1967;  66 1091-1096
• 4 Grossman E, Goldstein D S, Hoffman A, Keiser H R. Glucagon and clonidine testing in the diagnosis of pheochromocytoma.  Hypertension. 1991;  17 733-741
• 5 Levinson P D, Hamilton B P, Mersey J H, Kowarski A A. Plasma norepinephrine and epinephrine responses to glucagon in patients with suspected pheochromocytomas.  Metabolism. 1983;  32 998-1001
• 6 Suzuki S, Kawai K, Ohashi S. et al . Comparison of the insulinotropic activity of glucagon-superfamily peptides in rat pancreas perfusion.  Horm Metab Res. 1992;  24 458-461
• 7 Holst J J. Glucagon, glucagon-like peptide-1 and their receptors: an introduction.  Acta Physiol Scand. 1996;  157 309-315
• 8 Richter E A, Galbo H, Holst J J, Sonne B. Significance of glucagon for insulin secretion and hepatic glycogenolysis during exercise in rats.  Horm Metab Res.. 1981;  13 323-326
• 9 Adeghate E, Ponery A S, Wahab A. Effect of electrical field stimulation on insulin and glucagon secretion from the pancreas of normal and diabetic rats.  Horm Metab Res. 2001;  33 281-289
• 10 Nussdorfer G G, Bahcelioglu M, Neri G, Malendowicz L K. Secretin, glucagon, gastric inhibitory polypeptide, parathyroid hormone, and related peptides in the regulation of the hypothalamus-pituitary-adrenal axis.  Peptides. 2000;  21 309-324
• 11 Nowak M, Rebuffat P, Andreis P. et al . Dose-dependent biphasic effect of glucagon on aldosterone secretion in rats: In vitro and in vivo studies.  Med Sci Res. 1996;  24 795-796
• 12 Perea A, Clemente F, Martinell J. et al . Physiological effect of glucagon in human isolated adipocytes.  Horm Metab Res. 1995;  27 372-375
• 13 Albertin G, Aragona F, Gottardo L. et al . Human pheochromocytomas, but not adrenal medulla, express glucagon-receptor gene and possess an in vitro secretory response to glucagon.  Peptides. 2001;  22 597-600
• 14 Levey G S, Weiss S R, Ruiz E. Characterization of the glucagon receptor in a pheochromocytoma.  J Clin Endocrinol Metab. 1975;  40 720-723
• 15 Ehrhart-Bornstein M, Haidan A, Alesci S, Bornstein S R. Neurotransmitters and neuropeptides in the differential regulation of steroidogenesis in adrenocortical-chromaffin co-cultures.  Endocr Res. 2000;  26 833-842
• 16 Zimlichman R, Goldstein D S, Zimlichman S. et al . Angiotensin II increases cytosolic calcium and stimulates catecholamine release in cultured bovine adrenomedullary cells.  Cell Calcium. 1987;  8 315-325
• 17 Heldman E, Barg J, Vogel Z. et al . Correlation between secretagogue-induced Ca²⁺ influx, intracellular Ca²⁺ levels and secretion of catecholamines in cultured adrenal chromaffin cells.  Neurochem Int. 1996;  28 325-334
• 18 Holmes C, Eisenhofer G, Goldstein D S. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.  J Chromatogr B Biomed Appl. 1994;  653 131-138
• 19 Heid C A, Stevens J, Livak K J, Williams P M. Real time quantitative PCR.  Genome Res. 1996;  6 986-994